Florida-based biotechnology company Earth Science Tech (OTCQB: ETST), through its wholly owned subsidiaries, is focused on helping women by providing ways to assess and treat sexually transmitted infections (“STI”). A recent article discussing the company reads, “Subsidiary Earth Science Pharmaceutical is committed to bringing low-cost, noninvasive testing processes and vaccines for sexually transmitted infections to market to help women improve the quality of their lives. The company’s first medical device, Hygee, is a home kit designed as a modified panty liner to allow for the self-collection of a gynecological specimen that can be tested for two types of infections — chlamydia and gonorrhea. It gives women the ability to self-collect specimens in a nonclinical setting before sending them to a laboratory that will process the specimens and notify them if they test positive so that they can seek treatment. . . . The motivation behind the technology is to help women and girls in high-risk situations, who might not be willing or able to seek out assistance through traditional medical care facilities, take responsible action for their own well-being with the help of online ordering and home screening.”
To view the full article, visit http://cnw.fm/loTT6
About Earth Science Tech Inc.
Earth Science Tech offers the highest purity and quality high-grade, full-spectrum cannabinoid oil on the market. Studies by DV Biologics prove the company’s CBD oil formulation lowers cortisol and functions as a neuroprotectant, with positive-result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for these studies to the public, offering the most effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com.
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://cnw.fm/ETST
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CBDW? Ask our Editor
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
[email protected]
